|
Medlicott, N J; Foster, K A; Audus, K L et al. (1998) Comparison of the effects of potential parenteral vehicles for poorly water soluble anticancer drugs (organic cosolvents and cyclodextrin solutions) on cultured endothelial cells (HUV-EC). J Pharm Sci 87:1138-43
|
|
Stella, V J; Rajewski, R A (1997) Cyclodextrins: their future in drug formulation and delivery. Pharm Res 14:556-67
|
|
Rajewski, R A; Stella, V J (1996) Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J Pharm Sci 85:1142-69
|
|
Rajewski, R A; Traiger, G; Bresnahan, J et al. (1995) Preliminary safety evaluation of parenterally administered sulfoalkyl ether beta-cyclodextrin derivatives. J Pharm Sci 84:927-32
|
|
Scott, D O; Bindra, D S; Sutton, S C et al. (1994) Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats. Drug Metab Dispos 22:438-42
|
|
Bindra, D S; Williams, T D; Stella, V J (1994) Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG 400. Pharm Res 11:1060-4
|
|
Scott, D O; Bindra, D S; Stella, V J (1993) Plasma pharmacokinetics of lactone and carboxylate forms of 20(S)-camptothecin in anesthetized rats. Pharm Res 10:1451-7
|
